These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33105692)

  • 1. In Cellulo Evaluation of the Therapeutic Potential of NHC Platinum Compounds in Metastatic Cutaneous Melanoma.
    Charignon E; Bouché M; Clave-Darcissac C; Dahm G; Ichim G; Clotagatide A; Mertani HC; Telouk P; Caramel J; Diaz JJ; Bellemin-Laponnaz S; Bouvet P; Billotey C
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33105692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring diversity in platinum(iv) N-heterocyclic carbene complexes: synthesis, characterization, reactivity and biological evaluation.
    Bouché M; Bonnefont A; Achard T; Bellemin-Laponnaz S
    Dalton Trans; 2018 Aug; 47(33):11491-11502. PubMed ID: 30074048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of ABCB5 in BRAF inhibitor-resistant melanoma cell lines.
    Xiao J; Egger ME; McMasters KM; Hao H
    BMC Cancer; 2018 Jun; 18(1):675. PubMed ID: 29929490
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Bouché M; Vincent B; Achard T; Bellemin-Laponnaz S
    Molecules; 2020 Jul; 25(14):. PubMed ID: 32660104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical evaluation of the imipridone family, analogs of clinical stage anti-cancer small molecule ONC201, reveals potent anti-cancer effects of ONC212.
    Wagner J; Kline CL; Ralff MD; Lev A; Lulla A; Zhou L; Olson GL; Nallaganchu BR; Benes CH; Allen JE; Prabhu VV; Stogniew M; Oster W; El-Deiry WS
    Cell Cycle; 2017 Oct; 16(19):1790-1799. PubMed ID: 28489985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel cis-[(NHC)
    Rehm T; Rothemund M; Muenzner JK; Noor A; Kempe R; Schobert R
    Dalton Trans; 2016 Oct; 45(39):15390-15398. PubMed ID: 27603959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anticancer activity of an air-stable Pd(I)-NHC (NHC = N-heterocyclic carbene) dimer.
    Scattolin T; Bortolamiol E; Palazzolo S; Caligiuri I; Perin T; Canzonieri V; Demitri N; Rizzolio F; Cavallo L; Dereli B; Mane MV; Nolan SP; Visentin F
    Chem Commun (Camb); 2020 Oct; 56(81):12238-12241. PubMed ID: 32926011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentration-Dependent Dual Effects of Ciprofloxacin on SB-590885-Resistant BRAF
    Aldaghi SA; Jalal R
    Chem Res Toxicol; 2019 Apr; 32(4):645-658. PubMed ID: 30829029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological activity of ester- and amide-functionalized imidazolium salts and related water-soluble coinage metal N-heterocyclic carbene complexes.
    Pellei M; Gandin V; Marinelli M; Marzano C; Yousufuddin M; Dias HV; Santini C
    Inorg Chem; 2012 Sep; 51(18):9873-82. PubMed ID: 22946642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity of the selective pan-RAF inhibitor TAK-632 in BRAF inhibitor-resistant melanoma.
    Nakamura A; Arita T; Tsuchiya S; Donelan J; Chouitar J; Carideo E; Galvin K; Okaniwa M; Ishikawa T; Yoshida S
    Cancer Res; 2013 Dec; 73(23):7043-55. PubMed ID: 24121489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic added value of a trans-Sulfonamide-Platinum-Complex in human melanoma cell lines and synergism with cis-Platin.
    Agudo-López A; Prieto-García E; Alemán J; Pérez C; Díaz-García CV; Parrilla-Rubio L; Cabrera S; Navarro-Ranninger C; Cortés-Funes H; López-Martín JA; Agulló-Ortuño MT
    Mol Cancer; 2017 Feb; 16(1):45. PubMed ID: 28231799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platinum(ii) O,S complexes as potential metallodrugs against Cisplatin resistance.
    Hildebrandt J; Häfner N; Görls H; Kritsch D; Ferraro G; Dürst M; Runnebaum IB; Merlino A; Weigand W
    Dalton Trans; 2016 Nov; 45(47):18876-18891. PubMed ID: 27897281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ER stress promotes antitumor effects in BRAFi/MEKi resistant human melanoma induced by natural compound 4-nerolidylcathecol (4-NC).
    Alves-Fernandes DK; Oliveira ÉA; Faião-Flores F; Alicea-Rebecca G; Weeraratna AT; Smalley KSM; Barros SBM; Maria-Engler SS
    Pharmacol Res; 2019 Mar; 141():63-72. PubMed ID: 30550954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The first small molecules capable of strongly suppressing proliferation of cancer cells harboring BRAF class I/II/III mutations.
    Choi SH; Shin I; Kim N; Nam Y; Sim T
    Biochem Biophys Res Commun; 2020 Nov; 532(2):315-320. PubMed ID: 32873393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial complex I inhibitor deguelin induces metabolic reprogramming and sensitizes vemurafenib-resistant BRAF
    Carpenter EL; Chagani S; Nelson D; Cassidy PB; Laws M; Ganguli-Indra G; Indra AK
    Mol Carcinog; 2019 Sep; 58(9):1680-1690. PubMed ID: 31211467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative DNA double strand breaks and autophagy in the antitumor effect of sterically hindered platinum(II) complexes in NSCLCs.
    Chen F; Wang X; Jin X; Zhao J; Gou S
    Oncotarget; 2017 May; 8(19):30933-30955. PubMed ID: 28427237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vemurafenib: a guide to its use in unresectable or metastatic melanoma.
    Keating GM; Lyseng-Williamson KA
    Am J Clin Dermatol; 2013 Feb; 14(1):65-9. PubMed ID: 23329082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chelating Phosphine-N-Heterocyclic Carbene Platinum Complexes via Catalytic Asymmetric Hydrophosphination and Their Cytotoxicity Toward MKN74 and MCF7 Cancer Cell Lines.
    Seah JWK; Lee JXT; Li Y; Pullarkat SA; Tan NS; Leung PH
    Inorg Chem; 2021 Nov; 60(22):17276-17287. PubMed ID: 34709031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fasting boosts sensitivity of human skin melanoma to cisplatin-induced cell death.
    Antunes F; Corazzari M; Pereira G; Fimia GM; Piacentini M; Smaili S
    Biochem Biophys Res Commun; 2017 Mar; 485(1):16-22. PubMed ID: 27693581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting signal-transducer-and-activator-of-transcription 3 sensitizes human cutaneous melanoma cells to BRAF inhibitor.
    Wang X; Qu H; Dong Y; Wang G; Zhen Y; Zhang L
    Cancer Biomark; 2018; 23(1):67-77. PubMed ID: 30010109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.